RGX-121 Gene Therapy in Children 5 Years of Age and Over With MPS II (Hunter Syndrome)

Clinical trial NCT04571970 · COMPLETED

Trial details

NCT number: NCT04571970
Sponsor: REGENXBIO Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Mucopolysaccharidosis Type II (MPS II)

Start date: 2021-03-11
Primary completion: 2023-05-09
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.